FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Consumer Health Nupercainal Recall

Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz

Novartis Consumer Health · Lincoln, NE

Risk level
Class III
Reported by FDA
Mar 27, 2013
Recall ID
D-208-2013
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled Nupercainal starting Mar 7, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-208-2013 on Mar 27, 2013. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Product description

Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Lot numbers, UPCs & expiration codes

Lot #: a) 10109149, 10111499, 10117160, 10119603, and 10121763, Exp 4/13 to 8/13; b) 10109148, 10112258, 10113806, 10115615, 10117161, 10119604, 10119605, 10121782, and 10122762, Exp 3/13 to 9/13.

Where it was sold

Nationwide and Panama

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-208-2013
Classification
Class III
Status
Terminated
Recall initiated
Mar 7, 2013
FDA report date
Mar 27, 2013
Quantity
91,872/1-oz. tubes and 94,464/2-oz. tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-208-2013, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
64533
Address
10401 Hwy 6
Code information
Lot #: a) 10109149, 10111499, 10117160, 10119603, and 10121763, Exp 4/13 to 8/13; b) 10109148, 10112258, 10113806, 10115615, 10117161, 10119604, 10119605, 10121782, and 10122762, Exp 3/13 to 9/13.
Postal code
68517-9626
Report date
Mar 27, 2013
Product type
Drugs
Recall number
D-208-2013
Classification
Class III
Recalling firm
Novartis Consumer Health
Product quantity
91,872/1-oz. tubes and 94,464/2-oz. tubes
Termination date
Nov 26, 2014
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Distribution pattern
Nationwide and Panama
Recall initiation date
Mar 7, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 21, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-208-2013, published Mar 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls